Wearable Cardioverter-Defibrillator Used as a Telemonitoring System in a Real-Life Heart Failure Unit Setting

Background: In patients with reduced left ventricular ejection fraction (LVEF) who are at risk of sudden cardiac death, a wearable cardioverter-defibrillator (WCD) is recommended as a bridge to the recovery of LVEF or as a bridge to the implantation of a device. In addition to its function to detect...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Christian Blockhaus, Stephan List, Hans-Peter Waibler, Jan-Erik Gülker, Heinrich Klues, Alexander Bufe, Melchior Seyfarth, Buelent Koektuerk, Dong-In Shin
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	wearable cardioverter-defibrillator sudden cardiac death heart failure unit telemonitoring Medicine R
Acceso en línea:	https://doaj.org/article/50d1beb281544a1b9b9f4815adb578ae
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:50d1beb281544a1b9b9f4815adb578ae
record_format	dspace
spelling	oai:doaj.org-article:50d1beb281544a1b9b9f4815adb578ae2021-11-25T18:02:52ZWearable Cardioverter-Defibrillator Used as a Telemonitoring System in a Real-Life Heart Failure Unit Setting10.3390/jcm102254352077-0383https://doaj.org/article/50d1beb281544a1b9b9f4815adb578ae2021-11-01T00:00:00Zhttps://www.mdpi.com/2077-0383/10/22/5435https://doaj.org/toc/2077-0383Background: In patients with reduced left ventricular ejection fraction (LVEF) who are at risk of sudden cardiac death, a wearable cardioverter-defibrillator (WCD) is recommended as a bridge to the recovery of LVEF or as a bridge to the implantation of a device. In addition to its function to detect and treat malignant arrhythmia, WCD can be used via an online platform as a telemonitoring system to supervise patients’ physical activity, compliance, and heart rate. Methods: We retrospectively analyzed 173 patients with regard to compliance and heart rate after discharge. Results: Mean WCD wearing time was 59.75 ± 35.6 days; the daily wearing time was 21.19 ± 4.65 h. We found significant differences concerning the patients’ compliance. Men showed less compliance than women, and younger patients showed less compliance than patients who were older. Furthermore, we analyzed the heart rate from discharge until the end of WCD prescription and found a significant decrease from discharge to 4, 8, or 12 weeks. Conclusion: WCD can be used as a telemonitoring system to help the involved heart failure unit or physicians attend to and adjust the medical therapy. Furthermore, specific patient groups should be educated more intensively with respect to compliance.Christian BlockhausStephan ListHans-Peter WaiblerJan-Erik GülkerHeinrich KluesAlexander BufeMelchior SeyfarthBuelent KoektuerkDong-In ShinMDPI AGarticlewearable cardioverter-defibrillatorsudden cardiac deathheart failure unittelemonitoringMedicineRENJournal of Clinical Medicine, Vol 10, Iss 5435, p 5435 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	wearable cardioverter-defibrillator sudden cardiac death heart failure unit telemonitoring Medicine R
spellingShingle	wearable cardioverter-defibrillator sudden cardiac death heart failure unit telemonitoring Medicine R Christian Blockhaus Stephan List Hans-Peter Waibler Jan-Erik Gülker Heinrich Klues Alexander Bufe Melchior Seyfarth Buelent Koektuerk Dong-In Shin Wearable Cardioverter-Defibrillator Used as a Telemonitoring System in a Real-Life Heart Failure Unit Setting
description	Background: In patients with reduced left ventricular ejection fraction (LVEF) who are at risk of sudden cardiac death, a wearable cardioverter-defibrillator (WCD) is recommended as a bridge to the recovery of LVEF or as a bridge to the implantation of a device. In addition to its function to detect and treat malignant arrhythmia, WCD can be used via an online platform as a telemonitoring system to supervise patients’ physical activity, compliance, and heart rate. Methods: We retrospectively analyzed 173 patients with regard to compliance and heart rate after discharge. Results: Mean WCD wearing time was 59.75 ± 35.6 days; the daily wearing time was 21.19 ± 4.65 h. We found significant differences concerning the patients’ compliance. Men showed less compliance than women, and younger patients showed less compliance than patients who were older. Furthermore, we analyzed the heart rate from discharge until the end of WCD prescription and found a significant decrease from discharge to 4, 8, or 12 weeks. Conclusion: WCD can be used as a telemonitoring system to help the involved heart failure unit or physicians attend to and adjust the medical therapy. Furthermore, specific patient groups should be educated more intensively with respect to compliance.
format	article
author	Christian Blockhaus Stephan List Hans-Peter Waibler Jan-Erik Gülker Heinrich Klues Alexander Bufe Melchior Seyfarth Buelent Koektuerk Dong-In Shin
author_facet	Christian Blockhaus Stephan List Hans-Peter Waibler Jan-Erik Gülker Heinrich Klues Alexander Bufe Melchior Seyfarth Buelent Koektuerk Dong-In Shin
author_sort	Christian Blockhaus
title	Wearable Cardioverter-Defibrillator Used as a Telemonitoring System in a Real-Life Heart Failure Unit Setting
title_short	Wearable Cardioverter-Defibrillator Used as a Telemonitoring System in a Real-Life Heart Failure Unit Setting
title_full	Wearable Cardioverter-Defibrillator Used as a Telemonitoring System in a Real-Life Heart Failure Unit Setting
title_fullStr	Wearable Cardioverter-Defibrillator Used as a Telemonitoring System in a Real-Life Heart Failure Unit Setting
title_full_unstemmed	Wearable Cardioverter-Defibrillator Used as a Telemonitoring System in a Real-Life Heart Failure Unit Setting
title_sort	wearable cardioverter-defibrillator used as a telemonitoring system in a real-life heart failure unit setting
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/50d1beb281544a1b9b9f4815adb578ae
work_keys_str_mv	AT christianblockhaus wearablecardioverterdefibrillatorusedasatelemonitoringsysteminareallifeheartfailureunitsetting AT stephanlist wearablecardioverterdefibrillatorusedasatelemonitoringsysteminareallifeheartfailureunitsetting AT hanspeterwaibler wearablecardioverterdefibrillatorusedasatelemonitoringsysteminareallifeheartfailureunitsetting AT janerikgulker wearablecardioverterdefibrillatorusedasatelemonitoringsysteminareallifeheartfailureunitsetting AT heinrichklues wearablecardioverterdefibrillatorusedasatelemonitoringsysteminareallifeheartfailureunitsetting AT alexanderbufe wearablecardioverterdefibrillatorusedasatelemonitoringsysteminareallifeheartfailureunitsetting AT melchiorseyfarth wearablecardioverterdefibrillatorusedasatelemonitoringsysteminareallifeheartfailureunitsetting AT buelentkoektuerk wearablecardioverterdefibrillatorusedasatelemonitoringsysteminareallifeheartfailureunitsetting AT donginshin wearablecardioverterdefibrillatorusedasatelemonitoringsysteminareallifeheartfailureunitsetting
_version_	1718411678954029056

Wearable Cardioverter-Defibrillator Used as a Telemonitoring System in a Real-Life Heart Failure Unit Setting

Ejemplares similares